Cover Image

Methotrexate shows the same efficacy and safety in the real world in all subtypes of JIA as in the controlled trial

Saved in:

Bibliographic Details
Main Authors:	Foedvari I (Author), Wierk A (Author)
Format:	Book
Published:	BMC, 2008-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

4.4 Different phenotype of anaemia in systemic juvenile idiopathic arthritis (s-JIA) compared to anaemia in other subtypes of JIA
by: Hinze CH, et al.
Published: (2008)

The efficacy and safety of Tocilizumab in adults with refractory systemic onset JIA
by: Joly J, et al.
Published: (2011)

Efficacy and safety of methotrexate in alopecia areata
by: Mariana Hammerschmidt, et al.
Published: (2014)

Can inflammatory markers predict response to methotrexate in JIA? Results from the CHARM study
by: Roth J, et al.
Published: (2011)

A meta-analysis to estimate the "real" placebo effect in juvenile idiopathic arthritis (JIA) trials
by: Martini A, et al.
Published: (2011)

Characterising inflammatory markers in two childhood autoimmune diseases (JIA and JDM) pre and post methotrexate
by: Patrick F, et al.
Published: (2011)

Methotrexate showed efficacy both in Crohn's disease and ulcerative colitis, predictors of surgery were identified in patients initially treated with methotrexate monotherapy
by: Mengyao Wang, et al.
Published: (2022)

Efficacy And Safety Of Methotrexate In Psoriasis A Reappraisal
by: Kanwar Amrinder J, et al.
Published: (2000)

Jia Zhangke on Jia Zhangke
by: Berry, Michael
Published: (2022)

Jia Zhangke on Jia Zhangke
by: Berry, Michael
Published: (2022)

Physician assessment of disease activity in JIA subtypes. Analysis of data extracted from electronic medical records
by: Wang Deli, et al.
Published: (2011)

Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi Consensus
by: Giovanni Damiani, et al.
Published: (2023)

Polypoid melanoma and superficial spreading melanoma different subtypes in the same lesion
by: Renato Shintani Hikawa, et al.
Published: (2014)

Efficacy and safety of methotrexate treatment of juvenile localized scleroderma
by: Osminina MK, et al.
Published: (2008)

2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
by: Yokota S, et al.
Published: (2008)

EFFICACY AND SAFETY OF COMBINATION TREATMENT WITH ABATACEPT AND METHOTREXATE AND MONOTHERAPY WITH METHOTREXATE IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
by: V. A. Kel'tsev, et al.
Published: (2012)

Real-world efficacy and safety of apremilast monotherapy in the management of moderate-to-severe Psoriasis
by: Bela J Shah, et al.
Published: (2020)

The Efficacy and Safety Profile of Generic Intravenous Levetiracetam in a Real-World Setting
by: Preechaya Ruangritkul, MSc, et al.
Published: (2021)

Efficacy and safety of tofacitinib in rheumatoid arthritis: Nine years of real‐world data
by: Ali Ekin, et al.
Published: (2024)

Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study
by: Qiongwen Zhang, et al.
Published: (2023)

Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa
by: Kevin T. Savage, BA, et al.
Published: (2020)

The Pursuit of originality makes us all the same!
by: G M Sogi
Published: (2019)

ARE ALL THE PROLONGED DRUG FORMULATIONS OF NIFEDIPINE THE SAME?
by: V. G. Kukes, et al.
Published: (2016)

All diuretics used in the treatment of hypertension are not the same
by: Serkan Asil, et al.
Published: (2017)

Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study)
by: Diego Orsini, et al.
Published: (2024)

Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial
by: Ekaterina Alexeeva, et al.
Published: (2021)

Thalidomide: efficacy and side effects in juvenile idiopathic arthritis (JIA)
by: Alpigiani MG, et al.
Published: (2008)

Folate supplementation in patients with psoriasis treated with methotrexate - effect on safety and efficacy
by: Magdalena Żychowska, et al.
Published: (2014)

Total cumulative dose of methotrexate is not the same as continuous cumulative dose: A clinician's perspective
by: Binod K Khaitan, et al.
Published: (2020)

Generalizability in real‐world trials
by: Anatol‐Fiete Näher, et al.
Published: (2024)

EVALUATION OF EFFICACY AND SAFETY OF COMPLEX TREATMENT WITH INFLIXIMAB AND METHOTREXATE COMPARING WITH METHOTREXATE MONOTHERAPY OF CHILDREN WITH JUVENILE POLYARTICULAR IDIOPATHIC ARTHRITIS
by: V. A. Kel'tsev, et al.
Published: (2012)

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data
by: De Benedetti Fabrizio, et al.
Published: (2012)

Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA)
by: Hirani SP, et al.
Published: (2008)

Efficacy and Safety of Apatinib in Advanced Hepatocellular Carcinoma: A Multicenter Real World Retrospective Study
by: Zhuangzhuang Zheng, et al.
Published: (2022)

Efficacy and safety of belimumab in lupus nephritis patients: a real-world observational study in China
by: Meng Tan, et al.
Published: (2023)

Prefilled pen versus prefilled syringe: a pilot study evaluating two different methods of methotrexate subcutaneous injection in patients with JIA
by: Justyna Roszkiewicz, et al.
Published: (2020)

Drug Safety and Relevant Issues in the Real-World
by: Maria Antonietta Barbieri, et al.
Published: (2023)

Comparative efficacy and safety of local and systemic methotrexate injection in cesarean scar pregnancy
by: Peng P, et al.
Published: (2015)

Enhancing the Efficacy and Safety of Methotrexate Treatment: A Focus on Drug Interactions (Review)
by: S. A. Doktorova, et al.
Published: (2024)

Using real-world data for supporting regulatory decision making: Comparison of cardiovascular and safety outcomes of an empagliflozin randomized clinical trial versus real-world data
by: Ha Young Jang, et al.
Published: (2022)